global glp-1 market size 2025 Receptor Agonist Growth Analysis GLP-1 Agonists Market Exclusive Research

Read guide Eligibility BMI criteria, contraindications, and screening

Further, a clinical trial of over 3,000 people living with type 2 diabetes and chronic kidney disease found that semaglutide led to improvement for kidney, cardiovascular, and survival outcomes including a 24% reduced risk of kidney disease events and18% lower risk of major cardiovascular events compared to placebo

Therefore, Mounjaro insurance coverage focuses largely on diabetes management, leaving those looking for weight loss options to consider Zepbound instead, especially as insurance is more likely to cover it for weight management

GLP-1 and GIP both play important roles in regulating blood sugar levels and appetite